Singapore Offers Public Funds To Bridge Valley Of Death, But Can It Last? – BioMedical Asia
This article was originally published in PharmAsia News
Executive Summary
SINGAPORE - There is no dearth of research programs - the trouble is capital has evaporated and risk appetite is anorexic, BioMedical Asia speakers said in Singapore March 17